Bridge financing worth $4 million has been secured by Frederick, Md.-based molecular diagnostics firm Akonni Biosystems. The money will be used for continued development of the TruDx2000 platform, as well as to secure current good manufacturing practice compliance and ISO 13485 certification for the company's manufacturing facilities and processes, and expand its test menu in partnership with key opinion leaders and collaborators.
Sign up for AdvaMed SmartBrief
Medical technology news
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.